Table 1. Clinical and biological... | American Society of Hematology

Table 1.

Clinical and biological features of infant patient with ALL on Total 16

Case	Risk status	Age (y)	WBC (×10⁹/L)	Sex	Race	Lineage	Subtype	CNS status	Day 15 induction MRD∗	End of induction MRD∗	Outcome
1	High	0.71	31.1	F	White	B cell	KMT2A-MLLT10	CNS-3	1.38%	Neg	Alive CR1
2	Standard	0.82	61.8	M	Other	B cell	ACIN-NUTM1	Traumatic no blasts	Neg	Neg	Alive CR1
3	High	0.16	54.4	F	White	B cell	KMT2A-AFF1	Traumatic with blasts	Neg	Neg	Expired TRM
4	High	0.82	32.9	M	White	B cell	KMT2A-MLLT10	Traumatic no blasts	13.7%	Neg	Alive CR1
5	High	0.44	52	F	White	B cell	KMT2A-AFF1	Traumatic with blasts	Neg	Neg	Alive CR1
6	High	0.71	450	M	White	B cell	KMT2A-MLLT1	CNS-2	0.012%	0.07%	Alive CR1
7	Standard	0.79	11.2	M	White	B cell	Hyperdiploid 51+	CNS-3	0.006%	Neg	Alive CR1
8	High	0.52	411.9	M	White	B cell	KMT2A-EPS15	Traumatic with blasts	1.274%	Neg	Expired TRM
9	High	0.56	6.7	F	Other	B cell	KMT2A-MLLT1	CNS-2	Neg	ND†	Expired TRM
10	High	0.12	905.3	F	White	B cell	KMT2A-MLLT1	Traumatic with blasts	2.911%	0.011%	Expired TRM
11	High	0.2	95.8	F	Other	T cell	γδ T cell	Traumatic with blasts	31.73%	0.034%	Expired Relapse
12	High	0.18	125.3	M	White	B cell	KMT2A-AFF1	CNS-2	2.88%	Neg	Alive CR2

Case	Risk status	Age (y)	WBC (×10⁹/L)	Sex	Race	Lineage	Subtype	CNS status	Day 15 induction MRD∗	End of induction MRD∗	Outcome
1	High	0.71	31.1	F	White	B cell	KMT2A-MLLT10	CNS-3	1.38%	Neg	Alive CR1
2	Standard	0.82	61.8	M	Other	B cell	ACIN-NUTM1	Traumatic no blasts	Neg	Neg	Alive CR1
3	High	0.16	54.4	F	White	B cell	KMT2A-AFF1	Traumatic with blasts	Neg	Neg	Expired TRM
4	High	0.82	32.9	M	White	B cell	KMT2A-MLLT10	Traumatic no blasts	13.7%	Neg	Alive CR1
5	High	0.44	52	F	White	B cell	KMT2A-AFF1	Traumatic with blasts	Neg	Neg	Alive CR1
6	High	0.71	450	M	White	B cell	KMT2A-MLLT1	CNS-2	0.012%	0.07%	Alive CR1
7	Standard	0.79	11.2	M	White	B cell	Hyperdiploid 51+	CNS-3	0.006%	Neg	Alive CR1
8	High	0.52	411.9	M	White	B cell	KMT2A-EPS15	Traumatic with blasts	1.274%	Neg	Expired TRM
9	High	0.56	6.7	F	Other	B cell	KMT2A-MLLT1	CNS-2	Neg	ND†	Expired TRM
10	High	0.12	905.3	F	White	B cell	KMT2A-MLLT1	Traumatic with blasts	2.911%	0.011%	Expired TRM
11	High	0.2	95.8	F	Other	T cell	γδ T cell	Traumatic with blasts	31.73%	0.034%	Expired Relapse
12	High	0.18	125.3	M	White	B cell	KMT2A-AFF1	CNS-2	2.88%	Neg	Alive CR2

WBC, white blood cell.

MRD, minimal residual disease as determined by flow cytometry.

ND, not determined, patient expired before CCE and did not have an end of induction marrow.